Clinical parameters and emerging biomarkers of partial remission in pediatric type 1 diabetes: a systematic review
Standard-of-care biomarkers appear sufficient to identify PR and monitor its impact on glycemic outcomes. Emerging biological markers offer promising insights into the underlying mechanisms of PR. Well-powered studies are needed to clarify PR determinants and their therapeutic potential.
Authors
- Philippe A. Lysy (ORCID: https://orcid.org/0000-0003-1598-7998)
- Camille Dikranian
- Oumayma Hadara
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- Institut Universitaire de Recherche Clinique (FR)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3389/fendo.2026.1758848
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00